July 23, 2007
Prospector
Profile
07.1103
 
Repro-Med Systems, Inc. NAICS 339100
24 Carpenter Road Chester, NY 10918 Description Medical Equipment Mfg.
(845) 469-2042 Employees 20
http://www.repro-med.com/ Revenue (mil) 1.7340
  Income (mil) -0.2540
  Assets (mil) 1.1380
  Liability (mil) 1.7840
  (for the year ended 2007-02-28)
 
Category: Audit Concerns
 
Event: Meyler & Company LLC expressed doubts on the ability of Repro-Med Systems, Inc. to continue as a going concern after auditing its financial statements. Th auditor notes that the Company has an accumulated deficit of $3,427,011 and there are existing uncertain conditions the Company faces relative to its ability to obtain capital and operate successfully.
 
Intellectual Property: On August 9, 2005, a patent was issued for a new mechanical variable flow rate controller. Used with its FREEDOM60® Syringe Infusion System, this device enables the user to select from a number of flow rates while using just one set of tubing, allowing flow rates to be changed during the course of a single infusion to better meet the needs of the patient. In June 10, 2003, the Company received a patent #6,575,946 for its new Full Stop Protection®. This addition to the RES-Q-VAC® system prevents any fluids from exiting the system. It also holds patent #5,336,189 for a "Combination IV Pump & Disposable Syringe" which confers a unique syringe to IV pump interface design. This patent is for the FREEDOM60® Infusion System, an infusion therapy product. [SEC Filing 10-KSB 06-04-07]
 
Description: The Company is engaged in the design and manufacture of medical devices for medical respiratory products and infusion therapy worldwide.
 
Officers: Andrew I. Sealfon (Chair, Pres., Treas. & CEO); Paul Mark Baker (Dir.); Nathan Blumberg (Dir.); Remo Spagnoli (Dir.)
 
Auditor: Meyler & Company LLC
 
Securities: Common Stock-Symbol REPR.OB; OTC BB; 29,012,286 common shares outstanding as of February 28, 2007.
 
 
 
return to main page